18-59431404-C-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_133459.4(CCBE1):​c.*4504G>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.396 in 152,066 control chromosomes in the GnomAD database, including 12,715 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.40 ( 12714 hom., cov: 33)
Exomes 𝑓: 0.50 ( 1 hom. )

Consequence

CCBE1
NM_133459.4 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 0.623

Publications

2 publications found
Variant links:
Genes affected
CCBE1 (HGNC:29426): (collagen and calcium binding EGF domains 1) This gene is thought to function in extracellular matrix remodeling and migration. It is predominantly expressed in the ovary, but down regulated in ovarian cancer cell lines and primary carcinomas, suggesting its role as a tumour suppressor. Mutations in this gene have been associated with Hennekam lymphangiectasia-lymphedema syndrome, a generalized lymphatic dysplasia in humans. [provided by RefSeq, Mar 2010]
CCBE1 Gene-Disease associations (from GenCC):
  • Hennekam lymphangiectasia-lymphedema syndrome 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, G2P, Labcorp Genetics (formerly Invitae)
  • Hennekam syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 18-59431404-C-G is Benign according to our data. Variant chr18-59431404-C-G is described in ClinVar as Benign. ClinVar VariationId is 327594.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.652 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_133459.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CCBE1
NM_133459.4
MANE Select
c.*4504G>C
3_prime_UTR
Exon 11 of 11NP_597716.1Q6UXH8-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CCBE1
ENST00000439986.9
TSL:1 MANE Select
c.*4504G>C
3_prime_UTR
Exon 11 of 11ENSP00000404464.2Q6UXH8-1
CCBE1
ENST00000649564.1
c.*4504G>C
3_prime_UTR
Exon 12 of 12ENSP00000497183.1Q6UXH8-1
CCBE1
ENST00000650467.2
c.*4504G>C
3_prime_UTR
Exon 9 of 9ENSP00000496897.2A0A3B3IRL6

Frequencies

GnomAD3 genomes
AF:
0.396
AC:
60201
AN:
151944
Hom.:
12712
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.250
Gnomad AMI
AF:
0.589
Gnomad AMR
AF:
0.441
Gnomad ASJ
AF:
0.388
Gnomad EAS
AF:
0.670
Gnomad SAS
AF:
0.497
Gnomad FIN
AF:
0.508
Gnomad MID
AF:
0.320
Gnomad NFE
AF:
0.428
Gnomad OTH
AF:
0.409
GnomAD4 exome
AF:
0.500
AC:
2
AN:
4
Hom.:
1
Cov.:
0
AF XY:
0.00
AC XY:
0
AN XY:
2
show subpopulations
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AC:
0
AN:
0
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AC:
0
AN:
0
Other (OTH)
AF:
0.500
AC:
2
AN:
4

Age Distribution

Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.396
AC:
60214
AN:
152062
Hom.:
12714
Cov.:
33
AF XY:
0.403
AC XY:
29968
AN XY:
74318
show subpopulations
African (AFR)
AF:
0.250
AC:
10348
AN:
41474
American (AMR)
AF:
0.441
AC:
6737
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.388
AC:
1343
AN:
3464
East Asian (EAS)
AF:
0.670
AC:
3472
AN:
5180
South Asian (SAS)
AF:
0.496
AC:
2389
AN:
4818
European-Finnish (FIN)
AF:
0.508
AC:
5354
AN:
10544
Middle Eastern (MID)
AF:
0.327
AC:
96
AN:
294
European-Non Finnish (NFE)
AF:
0.428
AC:
29077
AN:
67990
Other (OTH)
AF:
0.408
AC:
862
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
1814
3629
5443
7258
9072
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
580
1160
1740
2320
2900
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.415
Hom.:
1697
Bravo
AF:
0.384
Asia WGS
AF:
0.536
AC:
1865
AN:
3478

ClinVar

ClinVar submissions as Germline
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
Hennekam lymphangiectasia-lymphedema syndrome 1 (1)
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
5.0
DANN
Benign
0.48
PhyloP100
0.62
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7230906; hg19: chr18-57098636; API